Nima Farzan
Fortune : 104 507 $ au 30/06/2026
Fortune : 104 507 $ au 30/06/2026
Nima M.
Farzan is President, Chief Executive Officer & Director at Latigo Biotherapeutics, Inc. since 2024.
Mr. Farzan is an Independent Director at Keros Therapeutics, Inc. since 2020.
Mr. Farzan is a Trustee at The Hamlin School.
Formerly, Mr. Farzan was President, Chief Executive Officer & Director at Kinnate Biopharma, Inc. from 2020 to 2024.
Mr. Farzan was President, Chief Executive Officer & Director at Emergent Travel Health, Inc. from 2015 to 2018.
Mr. Farzan was President & Chief Executive Officer at Paxvax Corp.
from 2015 to 2018.
Mr. Farzan was Director-Strategic Marketing at DoubleTwist, Inc. from 1997 to 1999.
Mr. Farzan was Director-Disease Area Strategy at Novartis AG from 2003 to 2011.
Mr. Farzan was Associate at The Boston Consulting Group, Inc. Mr. Farzan was Vice President-Marketing at Novartis Vaccines & Diagnostics, Inc. Mr. Farzan was Member at Coalition for Epidemic Preparedness Innovations.
Mr. Farzan was Venture Partner at Foresite Capital Management LLC in 2024.
Education includes undergraduate degree from Stanford University and MBA from Harvard Business School.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
KEROS THERAPEUTICS, INC. 0,05 % | 04/06/2026 | 9 767 ( 0,05 % ) | 104 507 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| KEROS THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/03/2020 |
The Hamlin School
The Hamlin School Other Consumer ServicesConsumer Services Operates as a school for girls | Corporate Officer/Principal | - |
Latigo Biotherapeutics, Inc.
Latigo Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage company that develops non-opioid pain medicines | Directeur Général | 22/07/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
Foresite Capital Management LLC
Foresite Capital Management LLC Investment ManagersFinance Foresite Capital Management invests in companies located in the US. The firm focuses on companies operating across a broad range of sectors. It provides financing for seed and later stage capital requirements. | Corporate Officer/Principal | 01/07/2024 |
| KINNATE BIOPHARMA INC. | Directeur Général | 03/04/2024 |
Emergent Travel Health, Inc.
Emergent Travel Health, Inc. BiotechnologyHealth Technology Provides biotechnical research services | Directeur Général | 01/10/2018 |
Paxvax Corp. | Directeur Général | 01/10/2018 |
| NOVARTIS AG | Corporate Officer/Principal | 01/01/2011 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 14 |
|---|---|
DoubleTwist, Inc.
DoubleTwist, Inc. Miscellaneous Commercial ServicesCommercial Services Provides genomic information and bioinformatics analysis | Commercial Services |
Emergent Travel Health, Inc.
Emergent Travel Health, Inc. BiotechnologyHealth Technology Provides biotechnical research services | Health Technology |
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Boston Consulting Group, Inc.
The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
Novartis Vaccines & Diagnostics, Inc.
Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
The Hamlin School
The Hamlin School Other Consumer ServicesConsumer Services Operates as a school for girls | Consumer Services |
Foresite Capital Management LLC
Foresite Capital Management LLC Investment ManagersFinance Foresite Capital Management invests in companies located in the US. The firm focuses on companies operating across a broad range of sectors. It provides financing for seed and later stage capital requirements. | Finance |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Keros Therapeutics, Inc.
Keros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics for muscle diseases | Health Technology |
Coalition for Epidemic Preparedness Innovations | |
Kinnate Biopharma, Inc.
Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage precision oncology company | Health Technology |
Latigo Biotherapeutics, Inc.
Latigo Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage company that develops non-opioid pain medicines | Health Technology |
Paxvax Corp. |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national